Navigation Links
Nephros Reports Second Quarter 2012 Financial Results
Date:8/14/2012

ssary regulatory approvals to achieve our business plan;
  • products that appeared promising to us in research or clinical trials may not demonstrate anticipated efficacy, safety or cost savings in subsequent pre-clinical or clinical trials;
  • we may encounter problems with our suppliers and manufacturers;
  • we may encounter unanticipated internal control deficiencies or weaknesses or ineffective disclosure controls and procedures;
  • HDF therapy may not be accepted in the United States and/or our technology and products may not be accepted in current or future target markets, which could lead to failure to achieve market penetration of our products;
  • we may not be able to effectively market our products, including our HDF system
  • we may not be able to sell our chronic renal failure therapy or water filtration products at competitive prices or profitably;
  • we may not be able to secure or enforce adequate legal protection, including patent protection, for our products; and
  • we may not be able to achieve sales growth in key geographic markets.
  • More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements, including the forward-looking statements in this press release, is set forth in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2011, and our other periodic reports filed with the SEC. We urge investors and security holders to read those documents free of charge at the SEC's web site at www.sec.gov. We do not undertake to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law.


    '/>"/>
    SOURCE Nephros, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Nephros Appoints John C. Houghton as President and Chief Executive Officer
    2. Nephros Receives 510(k) Clearance for Hemodiafiltration System
    3. Nephros Reports First Quarter 2012 Financial Results
    4. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    5. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    6. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    7. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    8. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
    9. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    10. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    11. Luminex Corporation Reports First Quarter 2012 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... Jan. 15, 2014  Novation, the leading health ... awarded several new IT value-added reseller (VAR) national ... organizations with IT goods and services at lower ... as well as value-added services such as initiative ... New Novation agreements were awarded to CDW ...
    (Date:1/15/2014)... -- BreedIT Corp (OTC: BRDT), through its ... highly sophisticated agro-breeding solutions for plant breeders and researchers, ... board of directors appointed chemistry and pharmaceutical industry expert ... of the board. From 1975 to 2012, ... Ltd (NYSE: TEVA ) and its subsidiaries ...
    (Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ... Symphony® CGM System as a non-invasive, wireless continuous ... F. Doman , Executive Chairman and Interim CEO ... Financial Capital Markets, Tenth Annual Equity Conference. ... presentation to prospective corporate partners and investors at ...
    Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
    ... Inc. magazine has ranked Universal SmartComp #503 ... fourth annual Inc. 5000, an exclusive ranking of the ... comprehensive look at the most important segment of the ... 7-Eleven, Brooklyn Brewery, and Radio Flyer, maker of the ...
    ... SILVER SPRING, Md., Sept. 24 The U.S. ... an estrogen/progestin combined oral contraceptive that also contains ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo: ... a metabolite of folic acid, a water-soluble B-vitamin ...
    Cached Medicine Technology:Universal SmartComp Ranks No. 503 Overall and No. 35 in the Health Sector on the 2010 Inc. 5000 with Three-Year Sales Growth of 600% 2Universal SmartComp Ranks No. 503 Overall and No. 35 in the Health Sector on the 2010 Inc. 5000 with Three-Year Sales Growth of 600% 3FDA Approves Combination Contraceptive Containing a Folate 2
    (Date:4/14/2014)... John DeLuca, PhD, and Yael Goverover, PhD, OT, have ... persons with multiple sclerosis (MS) perform everyday life tasks. ... Measure Everyday Life Functional Activity in Multiple Sclerosis" provides ... senior VP of Research & Training at Kessler Foundation. ... is a visiting scientist at Kessler Foundation. She was ...
    (Date:4/14/2014)... the answer to one open-ended question predicted the teenagers, offending ... think you,ll live?", According to the study, having little hope ... Piquero said the study found those who don,t view a ... rates and commit more serious offenses, while those who believe ... less., "In a lot of distressed communities and for a ...
    (Date:4/14/2014)... A new study identifies a molecule that is ... that the molecule could be an important target for ... progression. , The study of microRNA-135b (miR-135b) in two ... journal Cancer Cell and was led by ... Arthur G. James Cancer Hospital and Richard J. ...
    (Date:4/14/2014)... CHICAGO --- Depression can hit young fathers hard -- with ... of their children,s lives, a new Northwestern Medicine study has ... over the first five years of fatherhood for these young ... fathers and whom lived in the same home as their ... in the journal Pediatrics . , This study is ...
    (Date:4/14/2014)... around the world, many people live and work in ... block sunlight. And as the global population continues to ... will only spread. , To alleviate the problem, ... redirects sunlight onto narrow streets and alleyways. The panel ... at an angle, where it spreads sunlight onto the ...
    Breaking Medicine News(10 mins):Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Study identifies a likely key driver of colorectal cancer development and progression 2Health News:Young dads at high risk of depression, too 2Health News:Let the sun shine in: Redirecting sunlight to urban alleyways 2
    ... Inc. and Schering-Plough Corporation (NYSE: SGP) today announced ... new indication for REMICADE(R) (infliximab) allowing for the ... pediatric patients aged 6 to 17 years, who ... corticosteroid, an immunomodulator and primary nutrition therapy, or ...
    ... known as marijuana or ganja, can help in the ... when body tissues are attacked by its own immune ... the University of Bonn, used tetrahydrocannabinol (THC), the active ... found that it reduced skin allergies. ,However, ...
    ... been eradicated in Europe but new infections and drug resistant ... Thursday in Stockholm showed . "The public health systems in ... well protected but there is no room for complacency," Zsuzsanna ... Control (ECDC), said at a press conference. ,According ...
    ... among asylum seekers in Denmark has proportionally tripled since 2001 ... a study published Thursday . ,Sixty-seven asylum seekers ... percent of the total -- tried to end their lives ... to Help Refugees said. ,That contrasted with the ...
    ... found that that umbilical cord blood transplants may provide ... patients . ,The study was conducted by a ... the University of Minnesota. ,As part of ... patients who received unrelated bone marrow transplants with the ...
    ... Brazil, China, South Africa and Mexico-- which form 42 ... united front on the issue of climate change ... leaders. ,In a joint statement released after ... Silva of Brazil, Chinese President Hu Jintao, Indian Prime ...
    Cached Medicine News:Health News:Remicade(R) Get Approval for First and Only Biologic Treatment for Pediatric Crohn's Disease 2Health News:Cord Blood Yields Better Results Than Bone Marrow Transplant for Cancer Patients 2
    Universal Hub with Varying Blade Edge Diameters For Mounting the Blade to the Handle; Stainless Steel....
    2 Sided Pivoted Closed Ring Design,Pointed And Smooth Sides; in stainless steel....
    Blunt Tapered Tip in stainless steel....
    ... meet the high-quality and ... practices. The optional Profile ... accessory features a unique ... increases the accuracy of ...
    Medicine Products: